Work

Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-Month, single-arm, open-label clinical trial in patient-caregiver dyads

Year: 2010

Type: article

Study design: Clinical Trial

Source: Clinical Therapeutics

DOI: 10.1016/j.clinthera.2010.11.007

Authors: Judith Hey-Hadavi, Andreas Pleil, Larry C. Deeb, John S. Fuqua, Lawrence A. Silverman, Barry Reiner, Ron Newfield, Natasa Rajicic, Michael P. Wajnrajch, Jose F. Cara

Institutions: Pfizer (United States), University of Florida, Indiana University School of Medicine, Goryeb Children's Hospital, University of California San Diego, Rady Children's Hospital-San Diego

Language: English

Topic: Growth Hormone and Insulin-like Growth Factors

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, Pfizer, Novo Nordisk, Genentech

OpenAlex ID: W2078733399

FWCI: 0.968

Cites: 25

Cited by: 22

Related to: 10